Get the Stockscreener App
3.92
3.45%
-0.14
Pre-market:
3.98
0.06
+1.53%
Treace Medical Concepts Inc stock is traded at $3.92, with a volume of 857.00K.
It is down -3.45% in the last 24 hours and up +47.37% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
See More
Previous Close:
$4.06
Open:
$4.12
24h Volume:
857.00K
Relative Volume:
1.20
Market Cap:
$254.30M
Revenue:
$207.32M
Net Income/Loss:
$-61.04M
P/E Ratio:
-4.0931
EPS:
-0.9577
Net Cash Flow:
$-25.97M
1W Performance:
+11.05%
1M Performance:
+47.37%
6M Performance:
+41.52%
1Y Performance:
-30.86%
1-Day Range:
$3.80
$4.17
1-Week Range:
$3.385
$4.469
52-Week Range:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
3.92 | 254.30M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Treace Medical Concepts Balances Growth With Earnings Strain - TipRanks
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock - Investing.com UK
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock By Investing.com - Investing.com South Africa
Treace Medical (TMCI) CEO boosts direct stake with June share buys - Stock Titan
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock - Investing.com
Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases - Stock Titan
Treace to Present at the Sidoti Small Cap Conference - The Manila Times
TMCI Q1 2026 Earnings: Narrowed Loss Beats Expectations Amidst Operational FocusEarnings Call Transcript - newsline.com
Treace Medical CEO John Treace buys $177,915 in company stock By Investing.com - Investing.com Nigeria
Treace Medical CEO John Treace buys $177,915 in company stock - Investing.com
Treace Medical (TMCI) CEO buys 50,000 shares in open-market trade - Stock Titan
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com Australia
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
William Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (TMCI) Declines 2.11% as Stock Nears Key Support at $2.64Covered Call ETF - The Legal Advocate
Treace Medical Concepts, Inc. 8-K SEC Filing Details and Company Information (May 19, 2026) - Minichart
Treace Medical Shareholders Back Directors, Pay and Auditor - TipRanks
Treace Medical Concepts shareholders elect directors and approve key proposals - Investing.com Australia
Treace Medical Concepts shareholders elect directors and approve key proposals By Investing.com - Investing.com South Africa
Treace Medical (TMCI) shareholders elect directors and ratify auditor at 2026 meeting - Stock Titan
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Treace Medical (TMCI) receives 30,000 restricted stock units - Stock Titan
Treace Medical (NASDAQ: TMCI) director gets 30,000 RSUs, holds 75,243 - Stock Titan
Armistice Capital (TMCI) discloses 6.36M shares, 9.85% stake - Stock Titan
Treace Medical Concepts Q1 earnings call highlights - MSN
Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing - Moomoo
Treace Medical Concepts CEO John Treace buys $375,505 in shares By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John Treace buys $375,505 in shares - Investing.com
TMCI (TMCI) CEO John Treace purchases over 150,000 company shares in open market - Stock Titan
Bank of America (TMCI) reports 3.53M shares, 5.5% ownership - Stock Titan
Treace Medical Concepts, Inc. Shareholders Are Encouraged - GlobeNewswire
Treace Medical Concepts (TMCI) Price Target Decreased by 35.65% to 5.58 - MSN
Treace Medical Concepts Q1 Earnings Call Highlights - MarketBeat
Treace Medical Concepts: Q1 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Hikes on Q1 Numbers - Baystreet.ca
Treace Medical Concepts, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts By Investing.com - Investing.com Australia
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):